BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9043965)

  • 1. Role of plasma insulin concentration in regulating glucose and lipid metabolism in lean and obese Zucker rats.
    Noshiro O; Hirayama R; Shimaya A; Yoneta T; Niigata K; Shikama H
    Int J Obes Relat Metab Disord; 1997 Feb; 21(2):115-21. PubMed ID: 9043965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased content of GLUT4 in adipose tissue of obese Zucker rats.
    Shimaya A; Noshiro O; Hirayama R; Yoneta T; Niigata K; Shikama H
    Eur J Endocrinol; 1997 Dec; 137(6):693-700. PubMed ID: 9437239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats.
    Wasan KM; Zamfir C; Pritchard PH; Pederson RA
    J Pharm Sci; 2003 Feb; 92(2):281-8. PubMed ID: 12532378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the new oral antidiabetic agent (-)-BM 13.0913.Na on insulin resistance in lean and obese Zucker rats.
    Apweiler R; Kühnle HF; Ritter G; Schell R; Freund P
    Metabolism; 1995 May; 44(5):577-83. PubMed ID: 7752904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
    Alemzadeh R; Fledelius C; Bodvarsdottir T; Sturis J
    Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.
    Oakes ND; Thalén P; Hultstrand T; Jacinto S; Camejo G; Wallin B; Ljung B
    Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R938-46. PubMed ID: 16183630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
    Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
    Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
    Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
    Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of hyperinsulinemia to modulation of lipoprotein lipase activity in the obese Zucker rat.
    Boivin A; Deshaies Y
    Metabolism; 2000 Jan; 49(1):134-40. PubMed ID: 10647077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and endocrine effects of interleukin-1 in obese, diabetic Zucker fa/fa rats.
    del Rey A; Monge-Arditi G; Klusman I; Besedovsky HO
    Exp Clin Endocrinol Diabetes; 1996; 104(4):317-26. PubMed ID: 8886749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
    Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
    Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-soluble rice bran enzymatic extract attenuates dyslipidemia, hypertension and insulin resistance in obese Zucker rats.
    Justo ML; Rodriguez-Rodriguez R; Claro CM; Alvarez de Sotomayor M; Parrado J; Herrera MD
    Eur J Nutr; 2013 Mar; 52(2):789-97. PubMed ID: 22661284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
    Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA
    Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.
    Liu YL; Sennitt MV; Hislop DC; Crombie DL; Heyman RA; Cawthorne MA
    Int J Obes Relat Metab Disord; 2000 Aug; 24(8):997-1004. PubMed ID: 10951538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic consequences of fasting in old lean and obese Zucker rats.
    Triscari J; Bryce GF; Sullivan AC
    Metabolism; 1980 Apr; 29(4):377-85. PubMed ID: 6990175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats.
    Carrascosa JM; Molero JC; Fermín Y; Martínez C; Andrés A; Satrústegui J
    Diabetes Obes Metab; 2001 Aug; 3(4):240-8. PubMed ID: 11520303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
    Kazumi T; Hirano T; Odaka H; Ebara T; Amano N; Hozumi T; Ishida Y; Yoshino G
    Diabetes; 1996 Jun; 45(6):806-11. PubMed ID: 8635657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.